Can a cancer drug sharpen the mind and hands in advanced MS?

This study tests whether rituximab, a drug used for certain cancers and autoimmune diseases, can improve thinking and hand function in people with advanced secondary progressive multiple sclerosis (SPMS). About 46 participants with high disability will receive either rituximab or a placebo for one year. Researchers will measure changes in memory, hand speed, and quality of life.